AEGiS-Reuters: Scientists Shed Light on a Genetic Engine of Cancer

Reuters, Ltd.Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


Scientists Shed Light on a Genetic Engine of Cancer

Reuters NewMedia - Thursday November 16, 2000
David Morgan


PHILADELPHIA (Reuters) - HATs and tails may sound more like formal wear than the stuff of cutting-edge genetic research. But scientists on Thursday said both are critical to deciphering the genetic secrets of certain cancers.

By subjecting common yeast cells to painstaking molecular analysis, a team of biologists at the Philadelphia-based Wistar Institute have deciphered the structure and function of a tiny active protein belonging to a family of enzymes known as HATs, or histone acetyltransferases.

HAT enzymes activate genes in the nuclei of cells by leaving molecules on the "tails" of genetic proteins. Because the yeast enzyme studied by the Wistar team stimulates cell growth, researchers said understanding how it operates could lead to new drugs to fight cancers such as leukemia.

"This enzyme is like a machine. And what we've discovered is not only the shape of the machine but how its engine works," said Shelley Berger, a Wistar researcher and co-author of a study published in the journal Molecular Cell.

"Because we know how the enzyme works, it could help us to rationally design drugs that might inhibit its function."

The 108-year-old Wistar Institute is a nonprofit biomedical research institution dedicated to studying the basic mechanisms that underlie major diseases, including cancer and AIDS . Its scientists are responsible for current vaccines against rabies and rubella.

The latest study, funded by the National Institutes of Health, used X-rays to compose a three-dimensional image of the structure of a yeast protein called Esa1, which is similar to human enzymes implicated in the spread of leukemia and even HIV, the virus that causes AIDS.

By determining the tiny protein's structure, scientists were also able to figure out how it functions.

"Their modes of action are very similar. But there are also subtle differences we can exploit," said Ronen Marmorstein, a Wistar structural biologist and the study's senior author.

The enzymes act on histones, which are small proteins around which DNA coils to form structures called nucleosomes. Compact strings of nucleosomes form chromosomes, 23 pairs of which exist in every human cell.

Researchers say HATs activate genes by adding a molecule to a tail-like structure on the histones. That causes the DNA coil to relax, enabling the gene to operate. Histone deacetylases remove the molecule, causing the DNA to tighten and repressing genetic expression.

Wistar scientists said they work with common brewer's yeast because yeast cells are cheap and grow far faster than human cells, enabling studies to track the effects of genetic modifications in a fraction of the time.


001116
RE001116


Copyright © 2000 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .